Results 41 to 50 of about 694,618 (154)

OCCUPATIONAL AND ENVIRONMENTAL SAFETY IN THE TREATMENT OF PERITONEAL METASTASES USING THE PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY METHOD: A SCOPING REVIEW

Актуальные проблемы теоретической и клинической медицины
Peritoneal metastases are a common manifestation of malignant tumor progression in various locations. Despite the availability of systemic therapy and surgical approaches, many patients continue to face unmet clinical needs, reduced quality of life, and ...
A. L. Berkembayeva, Zh. K. Burkitbayev, J. А. Zainulina, Zh. M. Kuanysh, A. К. Kerimkulov, Z. Dushimova   +5 more
doaj   +1 more source

Gastric cancer treated with pressurized intraperitoneal aerosol chemotherapy: revising an option for peritoneal carcinomatosis [PDF]

, 2018
Aim: Gastric cancer is the cancer with the highest rate of peritoneal metastization and this type of spread is associated with a higher death rate compared to distant organ metastasis.
Kátia Ladeira, Longatto-Filho, Adhemar, Sandra F. Martins, Longatto, Adhemar, Macedo, Filipa, Ladeira, Kátia, Martins, Sandra F., Martins, Sandra, Adhemar Longatto-Filho, Filipa Macedo   +9 more
core   +1 more source

Implementation and evaluation of Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) for the treatment of patients with malignant pleural effusion: study protocol for the Danish phase-I PITAC-OPC5 study

Pleura and Peritoneum
Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) is a minimally invasive cancer-directed therapy for patients with malignant pleural effusion (MPE) and/or pleural metastasis (PLM). PITAC is based on Pressurized IntraPeritoneal Aerosol Chemotherapy,
Hansen Pernille Schjødt, Graversen Martin, Detlefsen Sönke, Ainsworth Alan Patrick, Fristrup Claus Wilki, Eckhoff Lise, Jelin-Klaric Mia, Mortensen Michael Bau   +7 more
doaj   +1 more source

Curcumin in the Treatment of Various Diseases: Mechanism of Action, Bioavailability, Therapeutic Effects, and Current Clinical Trials

MedComm, Volume 7, Issue 11, November 2026.
Curcumin, a naturally occurring polyphenol, exhibits significant anti‐inflammatory and antioxidant capabilities. This review elucidates the specific molecular mechanisms by which curcumin exerts therapeutic effects on various diseases, including neurological disorders, cardiovascular diseases, cancers, inflammatory disorders, and autoimmune diseases ...
Lin Wang, Qifei Pan, Wenjuan Long, Xinyao Li, Jianqin Mao, Sitong Zhou, Zihui Wang, Xuelian Zou, Yuqing She, Mingqin Shi, Yang Zhou, Jiarong Du, Zhongyang Hu, Xiaoman Lv, Yishu Chen, Dongdong Qin   +15 more
wiley   +1 more source

Preclinical Evaluation of Bacterial Lysates in Murine Disease Models: A Systematic Review

Immunity, Inflammation and Disease, Volume 14, Issue 10, October 2026.
ABSTRACT Background Bacterial lysates are biologically active preparations obtained by thermal, mechanical, or chemical inactivation of whole bacterial cells, preserving their immunomodulatory properties. Methods This systematic review evaluates preclinical studies published between 2010 and 2025 that investigated bacterial lysates in murine disease ...
Diana‐Larisa Ancuța, Cristin Coman
wiley   +1 more source

Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy:a systematic review [PDF]

, 2020
BACKGROUND: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is used in the palliative treatment of peritoneal metastasis. The combination of intraperitoneal and systemic chemotherapy seems rational, and the aim of this systematic review was to ...
Graversen, Martin, Mortensen, Michael Bau; id_orcid, Ploug, Magnus, Pfeiffer, Per; id_orcid   +3 more
core   +1 more source

MODERN STRATEGY IN TREATMENT OF PERITONEAL CARCINOMATOSIS

Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, 2017
Peritoneal carcinomatosis (PC) is a common manifestation of progression in peritoneal and gynecologic malignancies. Current primary strategy in treatment of PC is the concept of regional influence by the way of cytoreductive surgery and intraperitoneal ...
A. A. Zakharenko, D. A. Zaitcev, M. A. Belyaev, A. A. Trushin, O. A. Ten, A. S. Natkha, K. N. Vovin, V. A. Rybalchenko   +7 more
doaj   +1 more source

The Implementation of a PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) Program in Portugal

Acta Médica Portuguesa, 2022
N/a.
Tiago Bouça-Machado, Marisa Aral, Sara Meireles, Martin Graversen, Elisabete Barbosa   +4 more
doaj   +1 more source

Tumor Infiltrating Lymphocyte Therapy Combined With PD‐1/LAG‐3 Inhibition in Patients With Recurrent Platinum‐Resistant Ovarian Cancer

International Journal of Cancer, Volume 159, Issue 7, Page 1735-1749, 1 October 2026.
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg, Cathrine L. Lorentzen, Marie C. W. Westergaard, Trine Z. Iversen, Troels H. Borch, Marco Donia, Sigrid M. Mannering, Stine E. W. Banke, Özcan Met, Inge Marie Svane   +9 more
wiley   +1 more source

PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer

, 2018
BACKGROUND: Recurrent, platin-resistant ovarian cancer (rPROC) has a poor survival. Even with the AURELIA trial, which is the best available treatment today, progression-free survival (PFS) is still only 6.7 months from the start of the second-line ...
Scambia, Giovanni
core   +1 more source